Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by brad129on Oct 31, 2022 1:44pm
102 Views
Post# 35060662

RE:RE:Let’s see who actually cares?

RE:RE:Let’s see who actually cares?

That's a great observation which is why I made another purchase(we haven't seen any financing) but didn't answer what would make you personally happy? 1.6 in revenue would put a large smile on my face and have a great WOW factor on the Shareprice. I hope that option is what is happening, and so far I can admit I have been wrong on all previous predictions but sooner or later I hope my intuition is correct.




LithLover wrote: I've posted about it before.  In Q3 they had $90k in cash in June and added $177k in financing in Aug. They had a montrhly burn rate of $640k. So cash of $267k before revenue and a burn rate of $1.9 million.  A shortfall of at least $1.65 million.

So it's 1 of these 3 options or a combination:

1) Revenue $1.6 million or more for the quarter
2) Expenses reduced by $600k or more
3) Additional Convertible Debenture private placement or financing by insiders.  (Nothing filed so unlike the Aug 18 announcement where are the funds?).

In fact add another month (October) at a burn rate of $640k.  They would have a cummulative shortfall of $2.3 million since July 1.  Revenues would need to be $600k a month and growing or reduced expenses or more financing but they would have ran out of cash by now.  

Why would they only raised 177k back in August supposedly knowing they would just need more unless they expected revenues to climb and/or had reduced the burn rate?     





 

brad129 wrote: Revenue in the last quarter was about 1 million, what would it take for anyone to say this is moving in the right direction? A negative tho that baseline shows we are going in the wrong way. But let's here what would make you happy? we know there are people here that want nothing but complete failure but some actually believe and want the company to succeed. Anyone willing to put a number out? Mine is 1.2-1.5 the higher in that range the better I see adoption of our services.




<< Previous
Bullboard Posts
Next >>